Cited by 419

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Vaccine optimization for COVID-19: Who to vaccinate first?

Open access

Matrajt, Laura, Eaton, Julia, Leung, Tiffany, Brown, Elizabeth R.·2021·Science Advances

DOI 10.1126/sciadv.abf1374

Published version of a preprint

Open this paper in CoChat — free account

Abstract

The optimal use of COVID-19 vaccine depends mainly on how efficacious the vaccine is and how many doses are available.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/sciadv.abf1374

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Particle swarm optimization
Kennedy, J., & Eberhart, R. (2002) · Proceedings of ICNN'95 - International Conference on Neural Networks · doi:10.1109/icnn.1995.488968 · Cited by 58,192
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0686-2 · Cited by 38,430
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2019) · Apollo - University of Cambridge Repository · doi:10.17863/cam.64134 · Cited by 10,460
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,279
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
COVID-19 and Racial/Ethnic Disparities
Webb Hooper, M., Nápoles, A. M., & Pérez-Stable, E. J. (2020) · JAMA · doi:10.1001/jama.2020.8598 · Cited by 2,047
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak
Zhao, S., Lin, Q., Ran, J., Musa, S. S., Yang, G., Wang, W., Lou, Y., Gao, D., Yang, L., He, D., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.050 · Cited by 1,853
Continuous Multivariate Distributions: Models and Applications
Kotz, S., Balakrishnan, N., & Johnson, N. L. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722065 · Cited by 1,391
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data
Linton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,361
Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
Zhang, J., Litvinova, M., Liang, Y., Wang, Y., Wang, W., Zhao, S., Wu, Q., Merler, S., Viboud, C., Vespignani, A., et al. (2020) · Science · doi:10.1126/science.abb8001 · Cited by 1,107
Implementing the Nelder-Mead simplex algorithm with adaptive parameters
Gao, F., & Han, L. (2012) · Computational Optimization and Applications · doi:10.1007/s10589-010-9329-3 · Cited by 1,090
Serial interval of novel coronavirus (COVID-19) infections
Nishiura, H., Linton, N. M., & Akhmetzhanov, A. R. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.060 · Cited by 1,083
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2025179 · Cited by 1,021
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e1 · Cited by 891
Projecting social contact matrices in 152 countries using contact surveys and demographic data
Prem, K., Cook, A. R., & Jit, M. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005697 · Cited by 889
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., O'Reilly, K., Endo, A., Hellewell, J., Nightingale, E. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30133-x · Cited by 848
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020
Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., Fry, A. M., Cannon, D. L., Chiang, C.-F., Gibbons, A., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4130 · Cited by 647
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases
Du, Z., Xu, X., Wu, Y., Wang, L., Cowling, B. J., & Meyers, L. A. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200357 · Cited by 636
Derivative-Free and Blackbox Optimization
Audet, C., & Hare, W. (2017) · Springer series in operations research/Springer series in operations research and financial engineering · doi:10.1007/978-3-032-00906-7 · Cited by 499
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study
Jing, Q.-L., Liu, M.-J., Zhang, Z.-B., Fang, L.-Q., Yuan, J., Zhang, A.-R., Dean, N. E., Luo, L., Ma, M.-M., Longini, I., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30471-0 · Cited by 496
Optimizing Influenza Vaccine Distribution
Medlock, J., & Galvani, A. P. (2009) · Science · doi:10.1126/science.1175570 · Cited by 437
A Well Infant With Coronavirus Disease 2019 With High Viral Load
Kam, K.-Q., Yung, C. F., Cui, L., Tzer Pin Lin, R., Mak, T. M., Maiwald, M., Li, J., Chong, C. Y., Nadua, K., Tan, N. W. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa201 · Cited by 373
Racial Disparities in Incidence and Outcomes Among Patients With COVID-19
Muñoz-Price, L. S., Nattinger, A. B., Rivera, F., Hanson, R., Gmehlin, C. G., Perez, A., Singh, S., Buchan, B. W., Ledeboer, N. A., & Pezzin, L. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.21892 · Cited by 358
PySwarms: a research toolkit for Particle Swarm Optimization in Python
James V. Miranda, L. (2018) · The Journal of Open Source Software · doi:10.21105/joss.00433 · Cited by 343
Design and Analysis of Vaccine Studies
Halloran, M. E., Longini, I. M., & Struchiner, C. J. (2010) · Statistics for Biology and Health · doi:10.1007/978-0-387-68636-3 · Cited by 326
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
Bartsch, S. M., O'Shea, K. J., Ferguson, M. C., Bottazzi, M. E., Wedlock, P. T., Strych, U., McKinnell, J. A., Siegmund, S. S., Cox, S. N., Hotez, P. J., et al. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.06.011 · Cited by 324
COVID-19 vaccine development pipeline gears up
Mullard, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31252-6 · Cited by 228
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study
Qin, J., You, C., Lin, Q., Hu, T., Yu, S., & Zhou, X.-H. (2020) · Science Advances · doi:10.1126/sciadv.abc1202 · Cited by 215
Interpretation and Estimation of Vaccine Efficacy under Heterogeneity
Halloran, M. E., Haber, M., & Longini, I. M. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116498 · Cited by 193
Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
Makhoul, M., Ayoub, H. H., Chemaitelly, H., Seedat, S., Mumtaz, G. R., Al-Omari, S., & Abu-Raddad, L. J. (2020) · Vaccines · doi:10.3390/vaccines8040668 · Cited by 107
Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea
Lee, Y.-H., Hong, C. M., Kim, D., Lee, T. H., & Lee, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.201620 · Cited by 59
COVID-19 vaccines for all?
Usher, A. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31354-4 · Cited by 57
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study
Cohen, R., Jung, C., Ouldali, N., Sellam, A., Batard, C., Cahn-Sellem, F., Elbez, A., Wollner, A., Romain, O., Corrard, F., et al. (2020) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2020-000887 · Cited by 33
Salt substitution to lower population blood pressure
He, F. J., Tan, M., Song, J., & MacGregor, G. A. (2020) · Nature Medicine · doi:10.1038/s41591-020-0784-9 · Cited by 15

Research works printed but not linked: 6

R. Cohen, C. Jung, N. Ouldali, A. Sellam, C. Batard, F. Cahn-Sellem, A. Elbez, A. Wollner, O. Romain, F. Corrard, S. Aberrane, N. Soismier, R. Creidy, M. Smati-Lafarge, O. Launay, S. Bechet, E. Varon, C. Levy, Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic. medRxiv 2020.06.12.20129221 (2020).
Pfizer A phase 1/2/3 placebo-controlled randomized observer-blind dose-finding study to evaluate the safety tolerability immunogenicity and efficacy of SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals (2020) pp. 1–137.
Q.-L. Jing, M.-J. Liu, J. Yuan, Z.-B. Zhang, A.-R. Zhang, N. E. Dean, L. Luo, M. Ma, I. Longini, E. Kenah, Y. Lu, Y. Ma, N. Jalali, L.-Q. Fang, Z.-C. Yang, Y. Yang, Household secondary attack rate of COVID-19 and associated determinants. medRxiv 2020.04.11.20056010 (2020).
S. M. Bartsch, K. J. O’Shea, M. C. Ferguson, M. E. Bottazzi, S. N. Cox, U. Strych, J. A. McKinnell, P. T. Wedlock, S. S. Siegmund, P. J. Hotez, B. Y. Lee, How efficacious must a COVID-19 coronavirus vaccine be to prevent or stop an epidemic by itself. medRxiv 2020.05.29.20117184 (2020).
10.1016/0025-5564(78)90023-8 · doi:10.1016/0025-5564(78)90023-8
10.1371/journal.pone.0013767 · doi:10.1371/journal.pone.0013767

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Bubar, K. M., Reinholt, K., Kissler, S. M., Lipsitch, M., Cobey, S., Grad, Y. H., & Larremore, D. B. (2021) · Science · doi:10.1126/science.abe6959 · Cited by 775
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
(2021) · doi:10.1016/j.vaccine.2021.04.002 · Cited by 101
A model and predictions for COVID-19 considering population behavior and vaccination
Usherwood, T., LaJoie, Z., & Srivastava, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-91514-7 · Cited by 74
How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks
Grundel, S., Heyder, S., Hotz, T., Ritschel, T. K. S., Sauerteig, P., & Worthmann, K. (2020) · doi:10.1101/2020.12.22.20248707 · Cited by 40

See all 419

Authors: Matrajt, L., Eaton, J., Leung, T., & Brown, E. R.
Venue: Science Advances
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2021-02-05
Volume: 7
Issue: 6
ISSN: 2375-2548 (ISSN-L)
DOI: 10.1126/sciadv.abf1374
OpenAlex: W3128418047
Cited by: 419
References: 42
FWCI: 35.98
Type: journal article
Language: en
Open access: gold
Licence: creativecommons.org/licenses/by-nc/4.0/ (vor)
Funders: National Institute of Allergy and Infectious Diseases (1 UM1 AI148684-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Vaccine optimization for COVID-19: Who to vaccinate first?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources